tradingkey.logo
tradingkey.logo
Search

Revolution Medicines Jumps 16%; Tilray Gains 7%; Semiconductor Equipment Shares Jump With ASML Up 3%; AXT Falls 13% on Lowered Sales Outlook

TigerJan 9, 2026 9:28 AM
facebooktwitterlinkedin
View all comments0

Revolution Medicines, Inc. jumped over 16% in premarket trading as Merck is in talks to buy it, the Financial Times reported on Thursday, citing people familiar with the matter.

Semiconductor equipment shares jumped in premarket trading with ASML up 3%, Lam Research up 1.3%.

AXT shares dropped after the company cut its revenue outlook, citing China's reduction of export control permits. The stock shed 13% to $22.45 in premarket trading. Through the close, shares were up nearly fivefold over the past three months.

Tilray Inc. rose 7% in premarket trading after announcing a potential rescheduling of marijuana in the U.S. could boost its medical cannabis business.

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Comments (0)

Click the $ button, enter the symbol, and select to link a stock, ETF, or other ticker.

0/500
Commenting Guidelines
Loading...

Recommended Articles

tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.